Rimegepant shows efficacy in migraine prevention
The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.
The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.
Article by Christine Clark and Peter Mas-Mollinedo Interview by Peter Mas-Mollinedo Testing of hospital laboratory staff for antibodies to covid-19 revealed some interesting findings and led to questions… read more.
Article by Christine Clark and Peter Mas-Mollinedo Interview by Peter Mas-Mollinedo People often ask if there a case for using both the molecular test and the antigen test.
Understanding what the different tests mean and how they can be used most appropriately underpins the test and trace process.
CymaBay Therapeutics announced that the FDA lifted clinical holds on seladelpar for all three Investigational New Drug (IND) Applications in Nonalcoholic Steatohepatitis (NASH), Primary Biliary Cholangitis (PBC) and… read more.
Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.
Multiple myeloma is unique amongst cancers in that the diagnosis is made by the clinician, not the pathologist. The pathologist merely states that the patient has a clonal… read more.
by Bruce Sylvester: Botox injection into fat surrounding the heart helps prevent atrial fibrillation after bypass surgery, researchers reported on Oct. 20, 2015 in Circulation: Arrhythmia and Electrophysiology.
Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.
John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby. Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.
by Bruce Sylvester: Treatment of advanced melanoma with a combination of nivolumab (Opdivo™) and ipilimumab (Yervoy™) or with nivolumab alone increases progression-free survival over ipilimumab monotherapy, researchers reported… read more.
Advertisment